C878-1923 Screening compound: N-[2-(diethylamino)ethyl]-4-[(2-{[(4-fluorophenyl)methyl]sulfanyl}-3H-imidazo[4,5-c]pyridin-3-yl)methyl]benzamide

C878-1923 Screening compound: N-[2-(diethylamino)ethyl]-4-[(2-{[(4-fluorophenyl)methyl]sulfanyl}-3H-imidazo[4,5-c]pyridin-3-yl)methyl]benzamide
C878-1923 Screening compound: N-[2-(diethylamino)ethyl]-4-[(2-{[(4-fluorophenyl)methyl]sulfanyl}-3H-imidazo[4,5-c]pyridin-3-yl)methyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C878-1923
N-[2-(diethylamino)ethyl]-4-[(2-{[(4-fluorophenyl)methyl]sulfanyl}-3H-imidazo[4,5-c]pyridin-3-yl)methyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C878-1923

Molecular Formula

C27H30FN5OS (C27 H30 FN5 OS)

Compound Name

N-[2-(diethylamino)ethyl]-4-[(2-{[(4-fluorophenyl)methyl]sulfanyl}-3H-imidazo[4,5-c]pyridin-3-yl)methyl]benzamide

IUPAC name

N-[2-(diethylamino)ethyl]-4-[(2-{[(4-fluorophenyl)methyl]sulfanyl}-3H-imidazo[45-c]pyridin-3-yl)methyl]benzamide

SMILES

CCN(CC)CCNC(c1ccc(Cn2c(SCc(cc3)ccc3F)nc3c2cncc3)cc1)=O

InChI

InChI=1S/C27H30FN5OS/c1-3-32(4-2)16-15-30-26(34)22-9-5-20(6-10-22)18-33-25-17-29-14-13-24(25)31-27(33)35-19-21-7-11-23(28)12-8-21/h5-14,17H,3-4,15-16,18-19H2,1-2H3,(H,30,34)

InChI Key

JWNFVQCARHWJRH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14803071

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

491.63

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.306

Distribution Coefficient, logD

3.192

Water Solubility, LogSw

-3.83

Polar Surface Area

47.933

Acid Dissociation Constant (pKa)

12.39

Base Dissociation Constant (pKb)

8.48

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.60

C878-1923 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

GABA Library (7115 compounds)

Nucleic Acid Ligands (8311 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Eye
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C878-1923 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C878-1923?
Check Price and Availability of C878-1923, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C878-1923 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C878-1923
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C878-1923
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C878-1923 available by request